← back to search

Yaohui Tang

Shanghai Jiao Tong University · CN
Area of research
Neurology · Molecular Biology
Research interest
Research interests include Neuroinflammation and Neurodegeneration Mechanisms, Extracellular vesicles in disease, Neurogenesis and neuroplasticity mechanisms, and Nanoplatforms for cancer theranostics.
h-index
39
citations
5,130
works
133
NIH funding
primary concept
email

Recent publications

A simple polydopamine‐based platform for engineering extracellular vesicles with brain‐targeting peptide and imaging probes to improve stroke outcome
Journal of Extracellular Vesicles 2025cited by 24position: lastdoi
Hypoxanthine is a metabolic biomarker for inducing GSDME-dependent pyroptosis of endothelial cells during ischemic stroke
Theranostics 2024cited by 26position: lastdoi
Low-intensity focused ultrasound stimulation promotes stroke recovery via astrocytic HMGB1 and CAMK2N1 in mice
Stroke and Vascular Neurology 2024cited by 17position: middledoi
M2 Microglial Extracellular Vesicles Attenuated Blood-brain Barrier Disruption via MiR-23a-5p in Cerebral Ischemic Mice
Aging and Disease 2023cited by 31position: middledoi
Bio-clickable, small extracellular vesicles-COCKTAIL therapy for ischemic stroke
Journal of Controlled Release 2023cited by 24position: middledoi
M2 microglia-derived extracellular vesicles promote white matter repair and functional recovery via miR-23a-5p after cerebral ischemia in mice
Theranostics 2022cited by 143position: middledoi
Click chemistry extracellular vesicle/peptide/chemokine nanocarriers for treating central nervous system injuries
Acta Pharmaceutica Sinica B 2022cited by 88position: middledoi
Additional file 3 of ACT001 attenuates microglia-mediated neuroinflammation after traumatic brain injury via inhibiting AKT/NFκB/NLRP3 pathway
Open MIND 2022cited by 0position: middledoi
Additional file 2 of ACT001 attenuates microglia-mediated neuroinflammation after traumatic brain injury via inhibiting AKT/NFκB/NLRP3 pathway
Figshare 2022cited by 0position: middledoi
Additional file 4 of ACT001 attenuates microglia-mediated neuroinflammation after traumatic brain injury via inhibiting AKT/NFκB/NLRP3 pathway
Figshare 2022cited by 0position: middledoi
Stroke subtype-dependent synapse elimination by reactive gliosis in mice
Nature Communications 2021cited by 207position: middledoi
Oligodendrocyte Precursor Cells Transplantation Improves Stroke Recovery <i>via</i> Oligodendrogenesis, Neurite Growth and Synaptogenesis
Aging and Disease 2021cited by 38position: middledoi
M2 microglia-derived exosomes protect the mouse brain from ischemia-reperfusion injury via exosomal miR-124
Theranostics 2019cited by 488position: middledoi
Dl‐3‐N‐butylphthalide promotes angiogenesis and upregulates sonic hedgehog expression after cerebral ischemia in rats
CNS Neuroscience & Therapeutics 2019cited by 65position: middledoi
Viscoelastic characterization of injured brain tissue after controlled cortical impact (CCI) using a mouse model
Journal of Neuroscience Methods 2019cited by 31position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Guo‐Yuan Yang · Ruijin Hospital11 papers (2019–2025) · 5 papers (2019–2022)Zhijun Zhang · Zhejiang A & F University5 papers (2019–2025)Yongting Wang · California Institute for Regenerative Medicine5 papers (2019–2023)Lin Qi · Chinese PLA General Hospital5 papers (2022–2024)Yaying Song · Shanghai Jiao Tong University4 papers (2019–2023)Hao Chen · Nanjing University of Science and Technology4 papers (2022–2024)Jiaji Pan · Guangxi University4 papers (2019–2024)Muyassar Mamtilahun · Guangzhou Medical University4 papers (2021–2025)Fang Yuan · Xuzhou Medical College3 papers (2022–2022) · 3 papers (2021–2024)Xiang Li · University of Arizona3 papers (2022–2022)Wei Wang · Beijing Institute of Petrochemical Technology3 papers (2022–2022)Yong-Fang Li · Massachusetts Institute of Technology3 papers (2022–2025) · 3 papers (2022–2022)Jun Ding · Shanghai University3 papers (2022–2022)Lin Cai · Fudan University3 papers (2022–2022) · 3 papers (2022–2022) · 3 papers (2023–2025)Zhiming Xu · China Pharmaceutical University3 papers (2022–2022)